Controlling resistant bacteria with a novel class of β-lactamase inhibitor peptides: from rational design to in vivo analyses-Reference-Cited by-同舟云学术

Controlling resistant bacteria with a novel class of β-lactamase inhibitor peptides: from rational design to in vivo analyses

Published:2014-08-11 Issue:1 Volume:4 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Mandal Santi M.,Migliolo Ludovico,Silva Osmar N.,Fensterseifer Isabel C. M.,Faria-Junior Celio,Dias Simoni C.,Basak Amit,Hazra Tapas K.,Franco Octávio L.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep06015.pdf

Reference36 articles.

1. Levy, S. B. & Marshall, B. Antibacterial resistance worldwide: causes, challenges and responses. Nat. Med. 10, 122–129 (2004).

2. Sandora, T. J. & Goldmann, D. A. Preventing lethal hospital outbreaks of antibiotic-resistant bacteria. N Engl. J. Med. 367, 2168–70 (2012).

3. Turner, C. E. et al. Molecular analysis of an outbreak of lethal postpartum sepsis caused by Streptococcus pyogenes. J Clin Microbiol. 51, 2089–95 (2013).

4. Tse, H. et al. Molecular characterization of the 2011 Hong Kong scarlet fever outbreak. J. Infect Dis. 206, 341–51 (2012).

5. Walker, M. J. & Beatson, S. A. Epidemiology. Outsmarting outbreaks. Science 338, 1161–1162 (2012).

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CycP: A Novel Self-Assembled Vesicle-Forming Cyclic Antimicrobial Peptide to Control Drug-Resistant S. aureus;Bioengineering;2024-08-21

2. Anti-MRSA activity of chlorophenyl pyrrolo benzodiazepines compound;The Journal of Antibiotics;2024-06-18

3. MM-GBSA and QM/MM simulation-based in silico approaches for the inhibition of Acinetobacter baumannii class D OXA-24 β-lactamase using antimicrobial peptides melittin and RP-1;Chemical Physics Impact;2024-06

4. Synthesis of a tetralone derivative of ampicillin to control ampicillin-resistant Staphylococcus aureus;Biochemical and Biophysical Research Communications;2024-06

5. Enhancing the activity of β-lactamase inhibitory protein-II with cell-penetrating peptide against KPC-2-carrying Klebsiella pneumoniae;PLOS ONE;2024-01-26